Leddermix

Small molecule

MMansoura University

Leddermix is one of 20 small molecule programs targeting Periodontitis. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PeriodontitisActive, not recruiting

PeriodontitisPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

138 competitors in Periodontitis

#DrugCompanyPhaseTrials

Peridex

DDexcel Pharma Technologies Ltd.

Phase 3

10 2

Acanya

Pfizer

Phase 3

1 3

Curcumin

Merck & Co.

Phase 3

1 4

Cysteine Hydrochloride

Novartis

Phase 2

1 5

Calcium Hydroxide

MMansoura University

Phase 3

2 6

Glutamine

Sanofi

Phase 2

1 7

Calcium Intravenous Infsuion

MMansoura University

Phase 3

2 8

Minocycline Hcl

OOraPharma

Phase 3

1 9

Metapex

AAga Khan University

Phase 3

1 10

Boswellia

MMansoura University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Periodontitis2 trials

Effectiveness of Asiaticoside as Intracanal Medication on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis

Recruiting·MMansoura University·Phase 2/3·NCT06566508·36 enrolled

Investigate"Clinically" the Effectiveness of Boswellia Based Intracanal Medication Compared to Calcium Hydroxide Ca(OH)2 and Ledermix on the Levels of Bacteria and Inflammatory Cytokines in Root Canals and Periradicular Tissues of Teeth With Apical Periodontitis

Recruiting·MMansoura University·Phase 2/3·NCT06466538·36 enrolled

Inflammatory Cytokines1 trial

Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines

Recruiting·MMansoura University·Phase 2/3·NCT06453304·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Leddermix. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Leddermix compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Leddermix. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: MMansoura University

Leddermix

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Periodontitis2 trials

Inflammatory Cytokines1 trial

References

Drug Info

Quick Facts

Related News